117 related articles for article (PubMed ID: 24891182)
1. Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality.
Bogdan S; Klempfner R; Sabbag A; Luria D; Gurevitz O; Bar-Lev D; Lipchenca I; Nof E; Kuperstein R; Goldenberg I; Eldar M; Glikson M; Beinart R
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1188-95. PubMed ID: 24891182
[TBL] [Abstract][Full Text] [Related]
2. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction.
Moreira RI; Cunha PS; Rio P; da Silva MN; Branco LM; Galrinho A; Feliciano J; Soares R; Ferreira RC; Oliveira MM
J Interv Card Electrophysiol; 2018 Apr; 51(3):237-244. PubMed ID: 29460235
[TBL] [Abstract][Full Text] [Related]
3. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
[TBL] [Abstract][Full Text] [Related]
6. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.
Daly DD; Maran A; Hyer JM; Funke F; Waring A; Cuoco FA; Sturdivant JL; Leman RB; Gold MR
Pacing Clin Electrophysiol; 2016 Aug; 39(8):863-9. PubMed ID: 27197959
[TBL] [Abstract][Full Text] [Related]
8. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
[TBL] [Abstract][Full Text] [Related]
9. Renal function and mortality following cardiac resynchronization therapy.
Lin G; Gersh BJ; Greene EL; Redfield MM; Hayes DL; Brady PA
Eur Heart J; 2011 Jan; 32(2):184-90. PubMed ID: 21068051
[TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
[TBL] [Abstract][Full Text] [Related]
11. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
[TBL] [Abstract][Full Text] [Related]
12. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F
Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981
[TBL] [Abstract][Full Text] [Related]
13. Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy.
Kreuz J; Horlbeck F; Linhart M; Mellert F; Fimmers R; Schrickel J; Nickenig G; Schwab JO
Europace; 2012 Nov; 14(11):1596-601. PubMed ID: 22611058
[TBL] [Abstract][Full Text] [Related]
14. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
15. Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality.
Reitan C; Bakos Z; Platonov PG; Höijer CJ; Brandt J; Wang L; Borgquist R
Europace; 2014 Nov; 16(11):1603-9. PubMed ID: 24681763
[TBL] [Abstract][Full Text] [Related]
16. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
17. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
[TBL] [Abstract][Full Text] [Related]
18. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy.
Rickard J; Bassiouny M; Tedford RJ; Baranowski B; Spragg D; Cantillon D; Varma N; Wilkoff BL; Tang WH
Am J Cardiol; 2015 Jan; 115(1):82-5. PubMed ID: 25491007
[TBL] [Abstract][Full Text] [Related]
20. Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response.
Verbrugge FH; Dupont M; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Heart; 2013 Mar; 99(5):314-9. PubMed ID: 23038789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
